Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)- Dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9- Dihydroxy-, (4s)-
2. 7-t-butyldimethylsilyl-10-hydroxycamptothecin
3. 7-tert-butyldimethylsilyl-10-hydroxycamptothecin
4. Ar 67 Cpd
5. Ar-67 Cpd
6. Db 67
7. Db-67
1. Ar-67
2. 220913-32-6
3. Db-67
4. Ar67
5. Db 67; Silatecan
6. Db 67
7. Nsc-708298
8. 3yea04nv6h
9. Db67
10. (s)-11-(tert-butyldimethylsilyl)-4-ethyl-4,9-dihydroxy-1h-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4h,12h)-dione
11. (20s)-7-t-butyldimethylsilyl-10-hydroxycamptothecin
12. 1h-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione, 11-((1,1-dimethylethyl)dimethylsilyl)-4-ethyl-4,9-dihydroxy-, (4s)-
13. Nci60_038363
14. Ar 67 Cpd
15. Ar-67 Cpd
16. Unii-3yea04nv6h
17. Chembl412309
18. Gtpl8919
19. Schembl1266162
20. Dtxsid00176592
21. Ar 67
22. Nsc708298
23. Zinc170020689
24. Compound 14 [pmid:11052802]
25. Db12384
26. Nsc 708298
27. Q27074492
28. (20s)-7-tert-butyldimethysilyl-10-hydroxycamptothecin
29. (19s)-10-[tert-butyl(dimethyl)silyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione
30. 1h-pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4h,12h)dione, 11-[(1,1-dimethylethyl)dimethylsilyl]-4-ethyl-4,9-dihydroxy-, (4s)-
| Molecular Weight | 478.6 g/mol |
|---|---|
| Molecular Formula | C26H30N2O5Si |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 478.19239860 g/mol |
| Monoisotopic Mass | 478.19239860 g/mol |
| Topological Polar Surface Area | 100 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 982 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Silatecan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Silatecan, including repackagers and relabelers. The FDA regulates Silatecan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Silatecan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Silatecan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Silatecan supplier is an individual or a company that provides Silatecan active pharmaceutical ingredient (API) or Silatecan finished formulations upon request. The Silatecan suppliers may include Silatecan API manufacturers, exporters, distributors and traders.
click here to find a list of Silatecan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Silatecan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Silatecan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Silatecan GMP manufacturer or Silatecan GMP API supplier for your needs.
A Silatecan CoA (Certificate of Analysis) is a formal document that attests to Silatecan's compliance with Silatecan specifications and serves as a tool for batch-level quality control.
Silatecan CoA mostly includes findings from lab analyses of a specific batch. For each Silatecan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Silatecan may be tested according to a variety of international standards, such as European Pharmacopoeia (Silatecan EP), Silatecan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Silatecan USP).
LOOKING FOR A SUPPLIER?
